KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Current Assets Current Deferred Revenue Current Leases Goodwill Goodwill & Intangibles Liabilities and Shareholders Equity Liabilities from Discontinued Operations Liabilities from Discontinued Operations Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Pension Preferred Shares Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Treasury Shares

Cash Flow Statement

Daily Values

Growth Metrics

Clover Health Investments (CLOV) Preferred Stock Liabilities (2019 - 2020)

Clover Health Investments' Preferred Stock Liabilities history spans 2 years, with the latest figure at $447.7 million for Q4 2020.

For Q4 2020, Preferred Stock Liabilities changed 0.0% year-over-year to $447.7 million; the TTM value through Dec 2020 reached $447.7 million, changed 0.0%, while the annual FY2020 figure was $447.7 million, 0.0% changed from the prior year.
Preferred Stock Liabilities reached $447.7 million in Q4 2020 per CLOV's latest filing, roughly flat from $447.7 million in the prior quarter.
In the past five years, Preferred Stock Liabilities ranged from a high of $447.7 million in Q4 2019 to a low of $447.7 million in Q4 2019.